Life Sciences

Press Ganey Acquires Doctor.com, Acquires Majority Stake in Binary Fountain

  • by

What You Should Know: – Press Ganey advances the healthcare consumerism movement with acquisitions of Doctor.com and a majority stake in Binary Fountain. – Expanded technology platform enables industry-leading management of providers’ online brand and seamless Web-wide patient acquisition and loyalty strategies. Press Ganey today… Read More »Press Ganey Acquires Doctor.com, Acquires Majority Stake in Binary Fountain

Complimentary trend analysis report: Emerging trends in pancreatic cancer research

  • by

Pancreatic cancer sadly remains one of the most deadly cancers in existence, partly because it often goes undiagnosed until it has already metastasized. Finding new and better therapies to fight pancreatic cancer means accelerating the research. A new report just released from Elsevier’s Professional Services… Read More »Complimentary trend analysis report: Emerging trends in pancreatic cancer research

J.P. Morgan on the state of life sciences and strategies to fuel innovation [Sponsored]

  • by

In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has cast a bright light on the life sciences industry with startups raising venture funding at record levels as the virus has… Read More »J.P. Morgan on the state of life sciences and strategies to fuel innovation [Sponsored]

Insights begin with clean, reusable data

  • by

Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.

Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation

  • by

What You Should Know: – Castor raises $12M in Series A funding to further their support for COVID-19 research through clinical trial and data automation. – With 4,000 live studies and 2,000,000 enrolled patients across 90 countries, Castor will use the funding to further invest… Read More »Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation

THREAD Lands $50M for Decentralized Clinical Trial Research Platform

  • by

What You Should Know: – THREAD receives an additional $50 million capital commitment from Water Street and JLL Partners to expand its decentralized clinical trial research platform – THREAD is an innovative technology and service provider that increases participant engagement by enabling pharmaceutical companies and contract… Read More »THREAD Lands $50M for Decentralized Clinical Trial Research Platform

Bayer, Verizon Partner to Build Next-Gen Global Network Infrastructure

  • by

What You Should Know: – Bayer announced that it has chosen Verizon Business to build a next-gen global network infrastructure to support the pharmaceutical giant’s global business operations.  – Verizon will enhance Bayer’s existing network capabilities to enable easier and more cost-effective network management and will deploy next-generation… Read More »Bayer, Verizon Partner to Build Next-Gen Global Network Infrastructure

Moderna Leverages AWS Cloud Platform to Develop New Class of Vaccines and Therapeutics

  • by

What You Should Know: – Moderna, Inc., a biotechnology company pioneering a new class of messenger RNA (mRNA) medicines, has selected Amazon Web Services (AWS) as its preferred cloud provider, as well as its standard for analytics and machine learning workloads. – By building and scaling its… Read More »Moderna Leverages AWS Cloud Platform to Develop New Class of Vaccines and Therapeutics

Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap

  • by

Oliver Schacht, PhD, CEO of OpGen Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a… Read More »Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap

W2O Acquires Discern Health to Strengthen Value-Based Care Capabilities

  • by

What You Should Know: – W2O announced today the acquisition of Discern Health, a leading healthcare consultancy based in Washington, DC, and Baltimore, to strengthen its strategic capabilities in assisting clients with critical healthcare policy trends and value-based reimbursement models. – Discern Health brings experts with… Read More »W2O Acquires Discern Health to Strengthen Value-Based Care Capabilities

Virtual Behavioral Health Could Reduce Costs, Improve Patient Outcomes, Report Finds

  • by

What You Should Know: – A new Accenture report called “Breakthrough Behavioral Health Access: Think Virtual” finds that the use of virtual behavioral health could expand care for more than 53 million Americans facing these conditions. – Demand for behavioral health specialists significantly outweighs current… Read More »Virtual Behavioral Health Could Reduce Costs, Improve Patient Outcomes, Report Finds

Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

  • by

What You Should Know: – FUJIFILM Sonosite, Inc. launches its next-generation point-of-care (POCUS) ultrasound system – designed specifically for the clinicians on the front lines of medicine to treat patients more effectively.  – The product is expected to commercialize in the US, Australia and New… Read More »Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics

  • by

What You Should Know: – Repurpose.AI, has partnered with Scripps Research to discover drug candidates that may be repurposed to treat COVID-19.  – The partnership will leverage Repurpose.AI’s ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine, to discover… Read More »Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics

New Lighthouse Initiative to Provide De-identified Patient Data for VIRUS COVID-19 Registry

  • by

What You Should Know: – PointClickCare introduces the Lighthouse initiative, which will provide de‐identified data on COVID‐19 diagnosed patients, including demographics, vitals, medications and health‐related outcomes, in order to better understand health outcomes post‐ICU.  – Comprehensive data sets are especially critical tools in responding to crises like the current COVID-19… Read More »New Lighthouse Initiative to Provide De-identified Patient Data for VIRUS COVID-19 Registry

Cleveland Clinic Florida Opens Florida Research and Innovation Center

  • by

What You Should Know: – Cleveland Clinic Florida opens Florida Research and Innovation Center that will advance innovative translational research, focused on immuno-oncology and infectious diseases, including COVID-19. – The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with… Read More »Cleveland Clinic Florida Opens Florida Research and Innovation Center